Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2001
09/12/2001EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii
09/12/2001EP1032424B1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
09/12/2001EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
09/12/2001EP0863141B1 Substituted heteroaromatic derivatives
09/12/2001EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
09/12/2001EP0820450B1 N-substituted azaheterocyclic carboxylic acids and alkylesters thereof
09/12/2001EP0817775B1 Quinazoline derivatives
09/12/2001EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/12/2001EP0644878B1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS
09/12/2001CN1312807A Inhibitors of glycogen synthase kinase 3
09/12/2001CN1312806A Prodrugs of proton pump inhibitors
09/12/2001CN1312799A Bispiperidines as antithrombotic agents
09/12/2001CN1312733A Reactor comprising a contact tube bundle
09/12/2001CN1070854C Pesticidal 1-arylpyrazole-5-sulfinilimine derivatives
09/12/2001CN1070853C 10-acyloxy-10,11-dihydrodibenz/b,f/azepine-5-carboxamides useful for treating nervous system disorders
09/12/2001CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments
09/11/2001US6288267 Thioamide derivatives
09/11/2001US6288236 Benzimidazole compounds containing a benzoxazole or benzothiazole ring, and compositions and methods of use containing the same
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288233 Enantioselective alkylation of tricyclic compounds
09/11/2001US6288228 Triazine angiogenesis inhibitors
09/11/2001US6288225 Substituted benzolactam compounds as substance P antagonists
09/11/2001US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation
09/11/2001US6288083 Chemokine receptor antagonists and methods of use therefor
09/11/2001US6288082 Compounds such as 6,7-diethoxy-4-(indan-5-ylamino) -quinoline-3-carbonitrile used as antineoplastic agents and in the treatment of polycycstic kidney disease
09/11/2001US6288077 2,3-methano-amino acid compounds
09/11/2001US6288068 Administering 1,4-disubstited piperidine derivative; alzheimer*s disease, cognition activators; anticholinergic agents
09/11/2001US6288061 Imidazole derivatives
09/11/2001US6288055 Analgesic agents
09/11/2001CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists
09/11/2001CA2200742C Quinoxaline derivatives useful in therapy
09/11/2001CA2031570C Substituted cyclohexenes as central nervous system agents
09/07/2001WO2001064826A2 Composition and method for bleaching a substrate
09/07/2001WO2001064697A1 Ligand and complex for catalytically bleaching a substrate
09/07/2001WO2001064676A2 INHIBITORS OF p38-α KINASE
09/07/2001WO2001064672A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
09/07/2001WO2001064671A2 Haloimidazole derivatives and their use as muscarinic m3 and serotoninergic 5-ht4 receptors
09/07/2001WO2001064670A1 Novel cyclic amide derivatives
09/07/2001WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
09/07/2001WO2001064668A2 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors
09/07/2001WO2001064656A1 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001WO2001064654A1 Pyrimidine compounds
09/07/2001WO2001064652A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias
09/07/2001WO2001064651A1 3-thiomethylpyrazoles as pesticides
09/07/2001WO2001064645A2 Derivatives of quinoline as alpha-2 antagonists
09/07/2001WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
09/07/2001WO2001064642A2 Benzamides and related inhibitors of factor xa
09/07/2001WO2001064639A2 Pde iv inhibiting amides, compositions and pharmaceutical use
09/07/2001WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
09/07/2001WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
09/07/2001WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/07/2001WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
09/07/2001WO2001064631A2 Derives de polyfluoroalkylimidazole et leur utilisation en tant qu'antagonistes des recepteur muscariniques m3 et serotoniques 5-ht4
09/07/2001WO2001064226A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
09/07/2001WO2001064200A2 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
09/07/2001WO2001064197A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/07/2001WO2001007432A8 Aminopiperidine derivatives as antibacterials
09/07/2001WO2001000197A3 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
09/07/2001WO2000075107A3 Bradykinin receptor antagonists
09/07/2001CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
09/07/2001CA2401667A1 Pde iv inhibiting amides, compositions and pharmaceutical use
09/07/2001CA2401216A1 Ligand and complex for catalytically bleaching a substrate
09/07/2001CA2401039A1 Composition and method for bleaching a substrate
09/07/2001CA2400657A1 Derivatives of quinoline as alpha-2 antagonists
09/07/2001CA2400138A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
09/07/2001CA2400116A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
09/07/2001CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/07/2001CA2397657A1 Farnesyl protein transferase inhibitor combinations with platinum compounds
09/07/2001CA2397253A1 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
09/07/2001CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection
09/06/2001US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/06/2001US20010020095 High affinity for D4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression
09/06/2001US20010020087 Imidazolinone haptens and antigens and enzyme conjugates prepared therefrom
09/06/2001US20010020036 Synergistic mixtures
09/06/2001US20010020035 Certain fused pyrrolecarboxamides a new class of gaba brain receptor
09/06/2001US20010020024 Opioid analgesics
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001DE10010430A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-5-ethyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010426A1 Medicaments, especially for treating anemia, containing 6-(4-(acylamino)-phenyl)-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010425A1 Medicaments for treating anemia, containing new or known 6-(4-(acylamino)-phenyl)-5-methyl-dihydropyridazinones having erythropoietin sensitizing and erythropoiesis stimulating activity
09/06/2001DE10010423A1 New 6-(4-acylamino-phenyl)-2,5-methyl-dihydropyridazinones, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/06/2001DE10010422A1 New 6-(4-carboxy-phenyl)-dihydropyridazinone esters or amides, having erythropoietin sensitizing and erythropoiesis stimulating activity, useful for treating anemia
09/05/2001EP1130015A1 Pyridazinone derivatives
09/05/2001EP1129089A1 Spiro-indolines as y5 receptor antagonists
09/05/2001EP1129088A2 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
09/05/2001EP1129076A1 Tetrahydroisoquinoline derivatives as lhrh antagonists
09/05/2001EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
09/05/2001EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments
09/05/2001EP1129071A1 Phenyl-substituted cyclic enaminones
09/05/2001EP1129070A1 Neurotrophic diamide and carbamate agents
09/05/2001EP1025088B1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
09/05/2001EP0946545B1 Novel carboxy substituted cyclic carboxamide derivatives
09/05/2001EP0868423B1 Method for the synthesis of a benzimidazole compound
09/05/2001EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists
09/05/2001EP0830345B1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
09/05/2001EP0758322B1 Alpha-(pyrazol-3-yl)-oxymethylene-phenylbutenic acid methyl esters and the use thereof against harmful fungi or animal pests
09/05/2001EP0726269B1 Quinolinecarboxylic acid derivatives and salts thereof
09/05/2001EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS